Stefanie Rintoul

Stefanie Rintoul is an experienced professional in the biotechnology sector, currently serving as Director of Biotechnology at Newton Investment Management Group since August 2021. Prior to this role, Stefanie held the position of Associate Director of Biotechnology at UBS Asset Management from July 2018 to July 2021. Additional experience includes an MBA internship in Business Insights - Oncology at AstraZeneca in mid-2017 and a prior role as a Scientist in the Innovative Medicines R&D Program at the same company from January 2014 to July 2016. Stefanie's academic background includes a Master of Business Administration from Harvard Business School, a Master of Science in Biomedical Engineering from Carnegie Mellon University, and a Bachelor of Science in Biological Sciences from the University of Notre Dame.